Orphazyme
0 followers
‌
Danish biopharma company, listed on Nasdaq Copenhagen, with a late-stage drug pipeline, developing new treatment options for orphan protein-misfolding diseases.
Industries
Headquarters
Employees
Links
Org chart
Anders Vadsholt
CEO & CFO
Anders Fink V.
Chief Executive Officer
Similar companies
Owkin
4 followers
Emergent BioSolutions
4 followers
SpringWorks Therapeutics
4 followers
Biofourmis
4 followers
Quantum-Si
2 followers
EyePoint Pharmaceuticals
2 followers
Spero Therapeutics
2 followers
Gene by Gene
2 followers
Entrada Therapeutics
1 follower
Law Office of Bryan Fagan PLLC
71 followers
Newlight Technologies
1 follower
Discover companies